학술논문

Immune reconstitution, vaccine responses, and rituximab use after ex-vivo CD34-selected myeloablative allogenic hematopoietic cell transplantation
Document Type
Article
Source
In: Bone Marrow Transplantation. (Bone Marrow Transplantation, May 2024, 59(5):625-629)
Subject
Language
English
ISSN
14765365
02683369